Awards for “NOVARTIS PHARMACEUTICALS CORPORATION”
25 awards on this page · sorted by amount · page 2
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| HT001426PE027 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Defense | $578.75K | 2026-01-15 | 2026-01-15 | 325412 | ACQUISITION OF PLUVICTO AND LUTATHERA FOR RADIOLOGY PATIENTS. |
| HT001425PE011 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Defense | $402.59K | 2025-08-15 | 2025-09-15 | 325412 | SERVICE MAINTENANCE FOR DENTAL COMPRESSOR LOCATED AT DILORENZO TRICARE HEALTH CLINIC |
| 36C25025F0726 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $400.19K | 2025-09-01 | 2026-08-31 | 325412 | PLUVICTO RADIOPHARMACEUTICAL - CLEVELAND VAMC |
| 36C25226F0037 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $365.52K | 2025-11-07 | 2026-01-31 | 325412 | PLUVICTO RADIOPHARMACEUTICAL |
| 36C25026F0204 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $334.45K | 2026-01-05 | 2026-12-31 | 325412 | PLUVICTO 2026 CLEVELAND |
| 36C25026N0254 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $316.16K | 2026-01-01 | 2026-01-31 | 325412 | RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA |
| 36C25225N0482 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $297.48K | 2025-08-01 | 2025-08-01 | 325412 | LUTATHERA - LUTETIUM LU 177 DOTATATE |
| 36C24920N0244 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.57K | 2019-12-19 | 2020-01-28 | 325412 | DRUG TISAGENLECLEUCEL TRADE NAME KYMRIAH FOR CAR-T CELL THEARPY |
| 36C24920N0173 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.57K | 2019-10-18 | 2019-11-19 | 325412 | DRUG TISAGENLECLEUCEL TRADE NAME: KYMRIAH |
| 36C24219F0479 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.57K | 2019-07-31 | 2019-08-30 | 325412 | KYMRIAH |
| 36C24921N0367 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.56K | 2021-03-08 | 2021-03-12 | 325412 | PHARMACEUTICAL - TISAGENLECLEUCEL (KYMRIAH) |
| 36C24921N0323 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.56K | 2021-01-26 | 2021-01-29 | 325412 | KYMRIAH |
| 36C24921N0300 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.56K | 2021-01-12 | 2021-01-21 | 325412 | KYMRIAH CAR T CELL THERAPY - EMERGENCY |
| 36C25721N0069 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.53K | 2020-10-16 | 2021-10-16 | 325412 | KYMRIAH MEDICATION |
| 36C25720F02761 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.53K | 2020-06-02 | 2020-06-02 | 325412 | EMERGENCY KYMRIAH CANCER MEDICATION |
| 36C25720F0196 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.53K | 2020-04-03 | 2020-06-05 | 325412 | KYMRIAH (TISAGEN LECLEUCEL) CANCER MEDICATION |
| 36C24921N0254 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.53K | 2020-12-16 | 2020-12-26 | 325412 | KYMIRAH FOR PATIENT AT THE NASHVILLE VA MEDICAL CENTER |
| 36C24921N0177 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.53K | 2020-11-05 | 2020-11-05 | 325412 | CAR T CELLS (KYMRIAH INJ,SUSP) |
| 36C24920N0594 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.53K | 2020-07-15 | 2020-09-30 | 325412 | T CELL KYMRIAH FOR PATIENTS AT NASHVILLE VAMC |
| 36C24920N0575 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.53K | 2020-07-08 | 2020-08-07 | 325412 | KYMRIAH |
| 36C24920N0548 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.53K | 2020-06-25 | 2020-07-05 | 325412 | EMERGENCY DRUG ORDER FOR TVHS. |
| 36C24920N0454 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.53K | 2020-04-28 | 2020-05-04 | 325412 | EMERGENCY TISAGENLECLEUCEL |
| 36C24920N0346 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Veterans Affairs | $283.53K | 2020-02-26 | 2020-03-07 | 325412 | EMERGENCY TISAGENLECLEUCEL |
| HT941026FE013 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Defense | $275.81K | 2025-12-19 | 2026-01-02 | 325412 | PLUVICTO AND LUTATHERA INJECTIONS |
| HT941026FE027 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Defense | $205.77K | 2026-02-11 | 2026-09-30 | 325412 | PLUVICTO AND LUTATHERA INJECTION |